The Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in AprilPivot represents a differentiated solution for insulin-dependent adults still on multiple daily injections, representing a multi-billion-dollar marketCommercial expansion activities are expected to begin in Q4 2026
Post Views: 130



